| abstract |
A modified herpes simplex virus oncolytic expression vector, wherein the modified herpes simplex virus is a herpes simplex virus deficient for a γ1 34.5 gene, wherein the vector comprises a nucleic acid comprising a nucleotide sequence encoding the truncated GADD34 protein encoded by SEQ ID NO: 2, wherein said nucleotide sequence is operably linked to an expression control sequence. |